Author

Sara Rodríguez

University of MiamiORCID 0000-0002-0373-7169Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Sara Rodríguez1 paper · Instituto Murciano de Investigación Biosanitaria

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Gulum YenisehirliiD· 2 shared James Jarad DollariD· 2 shared Renata L. VolonterioiD· 2 shared Sebastian BorgesiD· 2 shared Stefan KurtenbachiD· 2 shared A. ZunigaiD· 1 shared Arnab ChakrabortyiD· 1 shared Ashley N. ZunigaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Gulum YenisehirliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 22, 2026

LMNA Haploinsufficiency in Human iPSC-Derived Cardiac Organoids Reveals Early Fibrotic Signaling as a Therapeutically Targetable Process

A. Zuniga, Raúl A Dulce, Karina Dutra Asensi…·Stefan Kurtenbach

This study uses cardiac organoids derived from patient iPSCs to show that LMNA haploinsufficiency causes early fibrotic signaling, which can be targeted by antifibrotic drugs.

DOI 10.64898/2026.03.25.714182

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCell Death and DiseasePeer-reviewedDec 12, 2025

Identification of targetable epigenetic vulnerabilities for uveal melanoma

Gulum Yenisehirli, Sebastian Borges, Steffanie S. Braun…·Stefan Kurtenbach

This study identifies BET inhibition as a promising therapeutic strategy for uveal melanoma by demonstrating its efficacy in reducing metastasis and improving survival in a mouse model.

7 citationstop 3%

mousebulk RNA-seq

𝕏 PostBluesky